Trials / Recruiting
RecruitingNCT04522687
Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer
Observation of the Impact of Radiotherapy With or Without Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets for Patients With Thoracic Cancer
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Shanghai Cancer Hospital, China · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is an observation, single center study to evaluate the alternations and prognostic value of peripheral blood lymphocyte (PBL) in patients diagnosed with thoracic cancers, including lung cancer, esophageal squamous cell carcinoma and thymic epithelial carcinoma underwent radiotherapy with or without chemotherapy.
Conditions
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2023-12-01
- Completion
- 2026-12-01
- First posted
- 2020-08-21
- Last updated
- 2020-08-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04522687. Inclusion in this directory is not an endorsement.